Search results

The 2023 Australian Synchrotron Stephen Wilkins Thesis Medal has been awarded to Dr Yanxiang Meng from the Walter & Eliza Hall Institute for Medical Research and the University of Melbourne for his research investigating the molecular mechanism at work in a form of programmed cell death, which is implicated in a variety of inflammatory diseases.

ANSTO’s Australian Synchrotron has been working on an initiative that could substantially improve radiotherapy treatment for cancer patients. 

$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.

The Imaging and Medical beamline (IMBL) is a flagship beamline of the Australian Synchrotron built with considerable support from the NHMRC. It is one of only a few of its type, and delivers the world’s widest synchrotron x-ray ‘beam’.

Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.

The User Advisory Committee (UAC) are pleased to present this year's invited speakers.

(ANSTO) has welcomed the launch of the new National Science Statement and revitalised National Science and Research Priorities by Minister for Industry and Science, The Hon Ed Husic MP and Australia’s Chief Scientist, Dr Cathy Foley AO PSM.

Researchers from the Health Research and Technology Group at ANSTO and the University of Wollongong have developed a new device that could improve the quality control of accelerator-based boron neutron capture therapy, a promising radiation therapy for treating aggressive cancers. 

The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.

The Hungarian Ambassador to Australia and a small delegation visited ANSTO for a special ceremony to mark the installation and commissioning of two new nuclear medicine scanners from the Hungarian company Mediso Pacific.

First Asia Oceania Forum held at the Australian Synchrotron

Congress marks watershed moment for nuclear medicine and ANSTO